Sun, Dec 28, 2014, 8:16 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • akanz2 akanz2 Nov 13, 2012 8:18 PM Flag

    The De Facto Informative Thread to quell the paid,misaligned Bashers/Shorts

    Good post .
    You might go on to explain that generic Lovaza ia basically a non issue .
    Those who have very low LDL cholesterol may continue taking Lovaza and will benefit from the generic version ----but for most CAD ( coronary artery disease ) patients ... its all about improving our lipid profile ( including lowering TG'S ) WITHOUT raising LDL cholesterol .

    The Anchor indication ( Vascepa with a statin drug ) IS the market for Vascepa ---10 x the size of the Marine indication . It address's the 200-500 TG range where Lovaza is NOT approved by the FDA , altho prescribed "off label "
    Once Vascepa is FDA approved for 200-500 TG range , very few MD's will write prescriptions for Lovaza for this patient group --- doesn't matter if Lovaza is generic or not. At least thats the view of my wife ( a physicans assistant ) ---and she writes prescriptions every working day.

    Lovaza ( in generic form or otherwise ) may still be used for very high TG's where pancreatitis is a concern ---- but for you typical mixed dyslipidemia patient --about 40 m of us ---where controlling LDL cholesterol is our chief concern ---- we will be taking Vascepa to reduce secondary risks associated with high TG's --- primarily in my case to eliminate the risk presented by high TG / low HDL ( Axis disorder ) identified in the Jelis trial .


    Sentiment: Buy

1.00+0.01(+0.85%)Dec 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
PG&E Corporation
NYSEFri, Dec 26, 2014 4:02 PM EST
Rice Energy Inc.
NYSEFri, Dec 26, 2014 4:02 PM EST